FDA Inspection
Eurofins Amatsi AnalyticsEurofins Amatsi Analytics – FDA Inspection, Nov 3, 2023
Record Details
This FDA Inspection record concerns Eurofins Amatsi Analytics, with an inspection on November 3, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · aed3d852-5c11-41b6-a617-8bef1b4eb2c9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1224183
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of Eurofins Amatsi Analytics
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 5, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 28, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 4, 2014 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| October 8, 2010 | NAI | Center for Veterinary Medicine | Pre-Approval Eval. of Animal Drugs and Food Additives |
Other documents for Eurofins Amatsi Analytics
- FDA Inspection 1174252 - 2021-08-05
- FDA Inspection 990192 - 2016-09-28
- FDA Inspection 865532 - 2014-02-04
- FDA Inspection 706532 - 2010-10-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.